Spider-Man: Into the Spider-Verse
| Symbol: | ASPDR |
| Status: | Inactive |
| Delist Date: | Jan 7, 2019 |
| Genre: | Animated |
| MPAA Rating: | PG |
| Phase: | Release |
| Release Date: | Dec 14, 2018 |
| Release Pattern: | wide |
| Gross: | $179,825,253 |
| Theaters: | 3813 |
Description
Phil Lord and Chris Miller produce an animated Spider-Man feature that centers on Miles Morales as the superhero.
Credits
Distributor
Sony
Director
Cast
Related Posts
HSX BlogMore »
-
Antibody – Jan 6, 2019
Box Score: Aquaman remains... Read »
-
Antibody – Dec 30, 2018
Box Score: Aquaman rules the... Read »
-
Antibody – Dec 23, 2018
Box Score: Aquaman starts off... Read »
-
Box Office Whisperer – Dec 20, 2018
Whisper Numbers: Aquaman vs.... Read »
-
Antibody – Dec 16, 2018
Box Score: Spider-Man soars... Read »
Forum DiscussionsMore »
-
Antibody – Dec 13, 2018
Theater Counts [BENIB]... Read »
-
Antibody – Dec 6, 2018
Theater Counts: estimates... Read »
-
Antibody – Nov 21, 2018
V tracking: [ASPDR] $25... Read »
-
tomcat90 – Oct 2, 2018
New trailer for 'Spider-Man:... Read »
-
Antibody – Jul 5, 2018
DF: Nicolas Cage is set to... Read »
-
-JPV- – Jun 6, 2018
Spider-Man: Into the... Read »
-
Antibody – Apr 25, 2018
GT: Jake Johnson voices Peter... Read »
-
Antibody – Dec 9, 2017
Teaser for Spider-Man: Into... Read »
-
warcraft86 – Jun 21, 2017
TB: Mahershala Ali and Brian... Read »
-
Antibody – Apr 27, 2017
New Release Dates: New... Read »
Spider-Man: Into the Spider-Vers (ASPDR)
H$133.98 January 7, 2019
Delist DateDelist Price
Shares Held Long on HSX: 0
Shares Held Short on HSX: 0
Trading Volume on HSX (Today): 670,600
High and Low Trading Prices
| This Week | H$133.01 | H$124.56 |
| This Month | H$137.72 | H$116.56 |
| This Season | H$137.72 | H$68.30 |
| This Year | H$137.72 | H$63.26 |
Quick HelpGlossary »
What is a: MovieStock®, Status, Change Today
Think you can manage?
Think you have what it takes to manage a Movie Fund? If you have a portfolio worth over H$100 million, then submit your fund idea proposal to macdaddy@hsx.com.